ESTROGEN GUY
VET
- Joined
- Aug 3, 2018
- Messages
- 2,326
A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men - PMC
A novel formulation of oral testosterone undecanoate (TU) was studied in a long- and short-term phase III trial to evaluate safety and efficacy. Hypogonadal men (age 18–65 years; two morning serum testosterone (T) <300 ng/dl with signs/symptoms) ...


Last edited: